Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefit VCAR33 ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with ...

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant Trem-cel + Mylotarg continue to ...

Navigating aircraft today isn’t like the old days. No more arrows painted on a barn roof or rotating airway beacons. Now, there are a host of radio navigation aids. GPS, of course, is available. But ...